483
Kofinas Fertility GroupFDA 483 - Kofinas Fertility Group - April 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kofinas Fertility Group in New York revealed significant deficiencies in their handling of reproductive human tissues. The firm failed to properly determine donor eligibility based on complete screening and testing, leading to potential communicable disease risks. Additionally, issues were identified with inadequate labeling of HCT/Ps and inaccurate or incomplete donor eligibility records.
Open in Dashboard
ID · 2cb620d5-1652-4c15-b89e-0813a4bb851b